Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,638 | 121 | 96.3% |
| Education | $102.76 | 3 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $446.97 | 29 | $0 (2023) |
| Astellas Pharma US Inc | $397.33 | 16 | $0 (2023) |
| PFIZER INC. | $278.16 | 6 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $230.01 | 13 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $173.84 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $117.04 | 3 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $109.16 | 6 | $0 (2022) |
| Accord Healthcare, Inc. | $99.28 | 1 | $0 (2022) |
| HealthTronics Mobile Solutions, LLC | $83.48 | 1 | $0 (2021) |
| AngioDynamics, Inc. | $74.27 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.70 | 3 | COLOPLAST CORP ($20.92) |
| 2023 | $255.27 | 11 | Endo Pharmaceuticals Inc. ($48.14) |
| 2022 | $424.49 | 13 | Accord Healthcare, Inc. ($99.28) |
| 2021 | $420.07 | 21 | Myriad Genetic Laboratories, Inc. ($90.29) |
| 2020 | $176.67 | 7 | PFIZER INC. ($79.60) |
| 2019 | $226.04 | 14 | AbbVie, Inc. ($83.27) |
| 2018 | $539.93 | 23 | Astellas Pharma US Inc ($116.25) |
| 2017 | $636.45 | 32 | Astellas Pharma US Inc ($180.10) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: UROLOGY | ||||||
| 04/24/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Prostate cancer | ||||||
| 02/02/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Continence Care | ||||||
| 11/07/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/21/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 09/11/2023 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Wound Closure | ||||||
| 08/30/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/22/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: UROLOGY | ||||||
| 08/08/2023 | Hollister Incorporated | VaPro (Device) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Continence Care | ||||||
| 07/31/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: HORMONE THERAPY | ||||||
| 04/17/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Urology | ||||||
| 03/30/2023 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 03/02/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/01/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: UROLOGY | ||||||
| 12/12/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/16/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diagnostic Imaging | ||||||
| 10/17/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Continence Care | ||||||
| 10/06/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 08/31/2022 | Accord Healthcare, Inc. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $99.28 | General |
| Category: Oncology | ||||||
| 08/19/2022 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $74.27 | General |
| Category: OS | ||||||
| 08/19/2022 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Analgesic| antispasmodic & antiseptic (urinary) | ||||||
| 08/15/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 08/11/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: UROLOGY | ||||||
| 06/02/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 02/17/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 393 | 505 | $72,598 | $23,316 |
| 2022 | 5 | 468 | 700 | $93,316 | $31,090 |
| 2021 | 5 | 564 | 801 | $110,415 | $38,138 |
| 2020 | 8 | 605 | 852 | $115,954 | $29,787 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 357 | $46,539 | $14,592 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 57 | $11,181 | $3,865 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 64 | $6,683 | $2,606 | 39.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 16 | 16 | $6,244 | $1,671 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,952 | $582.02 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 342 | 562 | $66,869 | $23,824 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 61 | $10,610 | $3,811 | 35.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 27 | 30 | $10,500 | $1,797 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,220 | $1,617 | 31.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 17 | $117.00 | $41.22 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 392 | 602 | $71,638 | $26,585 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 99 | $17,325 | $6,890 | 39.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 37 | 42 | $14,700 | $2,427 | 16.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $6,612 | $2,188 | 33.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 20 | $140.00 | $48.72 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 428 | 633 | $75,327 | $20,963 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 70 | $12,250 | $3,777 | 30.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 42 | 56 | $19,600 | $3,469 | 17.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,959 | $597.45 | 20.2% |
| 51702 | Insertion of indwelling bladder catheter | Office | 2020 | 11 | 25 | $4,050 | $487.90 | 12.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 19 | 22 | $1,540 | $412.58 | 26.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 18 | $126.00 | $53.24 | 42.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 13 | 17 | $102.00 | $26.95 | 26.4% |
About Dr. Timothy Morrow, M.D
Dr. Timothy Morrow, M.D is a Specialist healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558331868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Morrow, M.D has received a total of $2,741 in payments from pharmaceutical and medical device companies, with $61.70 received in 2024. These payments were reported across 124 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,638).
As a Medicare-enrolled provider, Morrow has provided services to 2,030 Medicare beneficiaries, totaling 2,858 services with total Medicare billing of $122,331. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Montgomery, AL
- Active Since 01/26/2006
- Last Updated 07/09/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1558331868
Products in Payments
- XTANDI (Drug) $420.45
- Myrbetriq (Drug) $200.38
- PROVENGE (Drug) $198.50
- XIAFLEX (Biological) $189.36
- Lupron (Drug) $114.66
- Androgel (Drug) $107.87
- ERLEADA (Drug) $101.64
- CAMCEVI (Drug) $99.28
- ORGOVYX (Drug) $94.02
- Mobile Cryoblation Services (Device) $83.48
- LUPRON DEPOT (Drug) $83.33
- Lupron Depot (Drug) $83.27
- NANOKNIFE (Device) $74.27
- Prolaris (Device) $73.72
- MYRBETRIQ (Drug) $68.98
- Erleada (Drug) $55.92
- Uribel (Drug) $47.98
- NOCDURNA (Drug) $46.52
- BOTOX (Biological) $43.33
- AVEED (Biological) $41.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Montgomery
Dr. Rosa Bell, Md, MD
Specialist — Payments: $20,679
Dr. John Robertson, M.d, M.D
Specialist — Payments: $15,644
Dr. Stephen Owens, M.d, M.D
Specialist — Payments: $10,634
Dr. Patrick Budny, M.d, M.D
Specialist — Payments: $8,612
Dr. Michael Bentley, M.d, M.D
Specialist — Payments: $7,374
Rafael Lopez, M.d, M.D
Specialist — Payments: $5,281